OC
OCAT

Oppenheimer & Co’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Oppenheimer & Co’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-79,700
Closed -$333K – 1438
2015
Q3 		$333K Buy
79,700
+63,100
+380% +$276K 0.01% 959
2015
Q2 		$87K Buy
+16,600
New +$106K ﹤0.01% 1411

Other funds holding OCAT

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oppenheimer & Co's OCAT Position: Q4 2015 in Review

Oppenheimer & Co sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q4 2015, closing a stake of 79,700 shares — an estimated $333K sold.

Oppenheimer & Co first reported a position in OCAT in Q2 2015 and held it in 2 quarters. The position peaked at $333K in Q3 2015. 77 funds tracked by Wall St. Rank hold OCAT as of Q4 2015.

  • Oppenheimer & Co reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 79,700 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q4 2015, an estimated $333K.
  • Oppenheimer & Co first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 2 quarters.
  • Oppenheimer & Co's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $333K in Q3 2015.
  • 77 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.